ALTOMARI ALFRED

Insider Buys Quantity –
11
2022-08-26PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
50,000
0.1417%
$0.45$22,500-51.05%
2021-10-13PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
58,824
<0.0001%
$0.85$50,000-79.52%
2021-07-29PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
26,200
<0.0001%
$1.26$33,096-72.15%
2021-05-18PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
20,000
<0.0001%
$1.61$32,200-55.66%
2021-03-23PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
12,500
<0.0001%
$2.00$25,030-47.07%
2020-12-07SaleInsmed Incorporated
INSM
director
40,000
0.0394%
$39.57$1.58M-24.76%
2020-02-27PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
20,000
<0.0001%
$2.71$54,200+4.01%
2019-06-10PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
40,000
<0.0001%
$1.27$50,800+53.54%
2019-03-25PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
50,000
<0.0001%
$1.54$77,000-3.59%
2019-02-26SaleInsmed Incorporated
INSM
director
11,000
0.0143%
$30.00$330,000-21.12%
2019-02-15SaleInsmed Incorporated
INSM
director
11,000
0.0144%
$27.50$302,500-13.63%
2019-02-05SaleInsmed Incorporated
INSM
director
11,000
0.0141%
$25.00$275,000-6.79%
2019-01-10SaleInsmed Incorporated
INSM
director
11,000
0.0142%
$22.50$247,500+4.64%
2017-08-25PurchaseAgile Therapeutics, Inc.
AGRX
Chairman & Chief Executive Off
20,000
<0.0001%
$3.34$66,800-4.2%
2017-05-11PurchaseAgile Therapeutics, Inc.
AGRX
Chairman and Chief Executive O
20,000
<0.0001%
$3.51$70,200+3.86%
2015-06-02PurchaseAgile Therapeutics, Inc.
AGRX
Chief Executive Officer
5,000
<0.0001%
$8.73$43,650-12.16%